Evidence map›Paper›PMID 41735826›Full record

ArticleBMC microbiology2026

Identification and functional characterization of Pseudomonas fluorescens as a novel intratumoral bacterium in colorectal cancer.

Qiliu Qian, Nan Li, Suna Cha, Shiya Zheng, Wenhao Li, Guangxuan Yin, Mingjun Sun, Ping Ye, Mingyue Hu, Ruihua Shi and 2 more

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qiliu Qian *Gastroenterology department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
Nan Li *Gastroenterology department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
Suna ChaSchool of Engineering, China Pharmaceutical University, Nanjing, 210009, China.
Shiya ZhengGastroenterology department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
Wenhao LiSchool of Engineering, China Pharmaceutical University, Nanjing, 210009, China.
Guangxuan YinSchool of Engineering, China Pharmaceutical University, Nanjing, 210009, China.
Mingjun SunKey Laboratory of Environment Medicine Engineering, School of Public Health, Ministry of Education, Southeast University, Nanjing, 210009, China.
Ping YeKey Laboratory of Environment Medicine Engineering, School of Public Health, Ministry of Education, Southeast University, Nanjing, 210009, China.
Mingyue HuGastroenterology department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
Ruihua ShiGastroenterology department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
Yongqi ZhangDepartment of Gastroenterology, Xuyi People's Hospital, Huaian, 211700, China. 13852315029@163.com.
Weitao ShenSchool of Engineering, China Pharmaceutical University, Nanjing, 210009, China. sddxswt@163.com.

Funding

National Natural Science Foundation of China Youth Foundation 81302162Open Project of Zhenjiang Traditional Chinese Medicine Spleen and Stomach Disease Clinical Medicine Research Center SSPW2022-KF06The National Natural Science Foundation of China 82303959Zhongda Hospital Affiliated to Southeast University, Jiangsu Province High-Level Hospital Construction Funds GSP-ZXY20
6 · The paper itself

Abstract

Colorectal cancer (CRC) remains a major global health burden as one of the leading causes of cancer-related mortality. Recent research has highlighted the crucial role of gut microbiota in CRC development. Through high-throughput full-length 16 S rDNA sequencing of tumor and adjacent non-tumor tissues from 14 CRC patients, significant microbial differences were identified. At the phylum level, Firmicutes (52.59%), Bacteroidetes (18.51%), and Proteobacteria (14.89%) dominated both tissue types, while at the genus level, Bacteroides (8.02%) and Escherichia (4.50%) showed the highest abundance. Notably, 17 bacterial species exhibited differential abundance between tumor and normal tissues, with Anaerotignum faecicola and Pseudomonas fluorescens being significantly enriched in tumor tissues. Functional prediction analysis revealed the microbiota’s predominant involvement in carbohydrate metabolism, amino acid metabolism, and energy metabolism pathways. Subsequent validation in 20 additional patient samples confirmed P. fluorescens enrichment in tumor tissues, and in vitro experiments demonstrated its ability to promote CRC cell viability and proliferation. These findings provide valuable insights into CRC-associated microbial signatures and suggest P. fluorescens as a potential contributor to tumor progression, offering new directions for developing diagnostic markers and therapeutic interventions in CRC management.

Indexed as

Colorectal NeoplasmsPseudomonas fluorescensBacteriaCell ProliferationDNA, BacterialFemaleGastrointestinal MicrobiomeHumansMaleMiddle AgedPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialRNA, Ribosomal, 16SBiomarkerColorectal cancerMetagenomic sequencingMicrobiotaPseudomonas fluorescens

Identifiers

PMID41735826
PMCPMC13036895

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.